Operating leverage with double-digit revenue growth and improving GAAP margins.
BUY under the locked decision engine; intrinsic value remains scenario-sensitive.
- Posture
- BUY under the locked decision engine; intrinsic value remains scenario-sensitive.
- Business phase
- 4
- Next proof
- Growth gate, Margin gate, Cash and dilution gate
- Valuation
- Unavailable
| # | KPI | Baseline | Next threshold | Signal | Investor read | Source |
|---|---|---|---|---|---|---|
| 1 | RevenueQ2 FY2026 | $1.3B | Stay at or above $1.2B | Above floor | The latest result remains on the safe side of the warning threshold. | Dexcom Q2 2026 Form 10-Q (2026-07-30) |
| 2 | Gross profitQ2 FY2026 | $830M | Next comparable update | Monitor | No comparable prior observation is in the public handoff; judge the next update against this baseline. | Dexcom Q2 2026 Form 10-Q (2026-07-30) |
| 3 | Operating income / EBITQ2 FY2026 | $318.3M | Next comparable update | Monitor | No comparable prior observation is in the public handoff; judge the next update against this baseline. | Dexcom Q2 2026 Form 10-Q (2026-07-30) |
| 4 | Gross marginQ2 FY2026 | 63.4% | Stay at or above 60% | Near threshold | The KPI is still on the safe side, but close enough that the next update matters. | Dexcom Q2 2026 Form 10-Q (2026-07-30) |
| 5 | Operating cash flow2026-06-30 | $794.8M | Next comparable update | Monitor | No comparable prior observation is in the public handoff; judge the next update against this baseline. | Dexcom Q2 2026 Form 10-Q (2026-07-30) |
| 6 | Operating marginQ2 FY2026 | 24.3% | Stay at or above 17% | Above floor | The latest result remains on the safe side of the warning threshold. | Dexcom Q2 2026 Form 10-Q (2026-07-30) |
| 7 | Net income attributable to commonQ2 FY2026 | $249.1M | Next comparable update | Monitor | No comparable prior observation is in the public handoff; judge the next update against this baseline. | Dexcom Q2 2026 Form 10-Q (2026-07-30) |
| 8 | Diluted weighted-average sharesQ2 FY2026 | 390.1M | Stay at or below 400M | Near threshold | The KPI is still on the safe side, but close enough that the next update matters. | Dexcom Q2 2026 Form 10-Q (2026-07-30) |
| 9 | Capital expenditures2026-06-30 | $161.3M | Next comparable update | Monitor | No comparable prior observation is in the public handoff; judge the next update against this baseline. | Dexcom Q2 2026 Form 10-Q (2026-07-30) |
| 10 | Interest ExpenseQ2 FY2026 | $2.2M | Next comparable update | Monitor | No comparable prior observation is in the public handoff; judge the next update against this baseline. | Dexcom Q2 2026 Form 10-Q (2026-07-30) |
| 11 | Total debt2026-06-30 | $1.2B | Next comparable update | Monitor | No comparable prior observation is in the public handoff; judge the next update against this baseline. | Dexcom Q2 2026 Form 10-Q (2026-07-30) |
| 12 | Free cash flow2026-06-30 | $633.5M | Stay at or above $0 | Above floor | The latest result remains on the safe side of the warning threshold. | Dexcom Q2 2026 Form 10-Q (2026-07-30) |
| 13 | Cash and equivalents2026-06-30 | $1.1B | Next comparable update | Monitor | No comparable prior observation is in the public handoff; judge the next update against this baseline. | Dexcom Q2 2026 Form 10-Q (2026-07-30) |
| 14 | Net IncomeQ2 FY2026 | $249.1M | Next comparable update | Monitor | No comparable prior observation is in the public handoff; judge the next update against this baseline. | Dexcom Q2 2026 Form 10-Q (2026-07-30) |
How to read the scorecard: Signals compare the latest baseline with the stated decision threshold. “Monitor” means the public handoff has one valid baseline but no compatible prior observation; it is not a positive or negative call.
KPI ontology coverage
Company definitions: 0. Coverage: No compatible sector, subsector, or business-model module was evidenced.; Company definition is supported only by private or local provenance.; Company definition is supported only by private or local provenance.; Company definition is supported only by private or local provenance.; Company definition is supported only by private or local provenance.; Company definition is supported only by private or local provenance.; Company definition is supported only by private or local provenance.; Company definition is supported only by private or local provenance.; Company definition is supported only by private or local provenance.; Company definition is supported only by private or local provenance.
| Module | Level | Version |
|---|---|---|
| Special situations | cross_cutting | v1 |
| Universal financial core | universal | v1 |
Quarterly KPI trajectory
Coverage: 117 reported observations across a 12-quarter snapshot; 41 explicit gaps. 44 derived from aligned ytd, 73 reported. Acquisition status: not public.
| KPI | Current | Previous quarter | Year ago | QoQ | YoY | Eight-quarter trend | Management explanation | Investor interpretation | Source |
|---|---|---|---|---|---|---|---|---|---|
| Interest Expense | $2.2M (Q2 FY2026) | $2.1M (Q1 FY2026) | $3.8M (Q2 FY2025) | +4.8% | -42.1% | $3.7M → $3.8M → $3.7M → $3.7M → $3.8M → $3.7M → $2.1M → $2.2M | No supported explanation | improving; no threshold configured; confidence high | Primary source (2026-07-30) |
| Net Income | $249.1M (Q2 FY2026) | $199.5M (Q1 FY2026) | $179.8M (Q2 FY2025) | +24.9% | +38.5% | $146.4M → $143.5M → $134.6M → $105.4M → $179.8M → $283.8M → $199.5M → $249.1M | The accepted Q2 filing reports the GAAP measures but does not provide a quantified driver bridge for every line; the related move is retained as an explicit unexplained reported change rather than attributed to a single cause. (unknown) | improving; no threshold configured; confidence high | Primary source (2026-07-30) |
| Capital expenditures | $84.7M (Q2 FY2026) | $76.6M (Q1 FY2026) | $94.1M (Q2 FY2025) | +10.6% | -10.0% | $56.9M → $66.1M → $111.2M → $87M → $94.1M → $80.5M → $76.6M → $84.7M | The accepted Q2 filing reports the GAAP measures but does not provide a quantified driver bridge for every line; the related move is retained as an explicit unexplained reported change rather than attributed to a single cause. (unknown) | improving; no threshold configured; confidence high | Primary source (2026-07-30) |
| Cash and equivalents | $1.1B (Q2 FY2026) | — | — | — | — | $1.1B | No supported explanation | insufficient_data; no threshold configured; confidence low | Primary source (2026-07-30) |
| Diluted EPS | 0.64 (Q2 FY2026) | 0.51 (Q1 FY2026) | 0.45 (Q2 FY2025) | +25.5% | +42.2% | 0.36 → 0.35 → 0.34 → 0.27 → 0.45 → 0.7 → 0.51 → 0.64 | The accepted Q2 filing reports the GAAP measures but does not provide a quantified driver bridge for every line; the related move is retained as an explicit unexplained reported change rather than attributed to a single cause. (unknown) | improving; no threshold configured; confidence high | Primary source (2026-07-30) |
| Diluted weighted-average shares | 390.1M (Q2 FY2026) | 393.6M (Q1 FY2026) | 408.2M (Q2 FY2025) | -0.9% | -4.4% | 416.7M → 416.8M → 410.2M → 407.5M → 408.2M → 407.4M → 393.6M → 390.1M | No supported explanation | improving; no threshold configured; confidence high | Primary source (2026-07-30) |
| Free cash flow | $184.5M (Q2 FY2026) | $449M (Q1 FY2026) | $208.9M (Q2 FY2025) | -58.9% | -11.7% | $152.3M → $213.3M → $88.3M → $96.8M → $208.9M → $579.4M → $449M → $184.5M | The accepted Q2 filing reports the GAAP measures but does not provide a quantified driver bridge for every line; the related move is retained as an explicit unexplained reported change rather than attributed to a single cause. (unknown) | deteriorating; no threshold configured; confidence high | Primary source (2026-07-30) |
| Gross margin | 63.4% (Q2 FY2026) | 62.9% (Q1 FY2026) | 59.5% (Q2 FY2025) | +49 bps | +391 bps | 61% → 62.4% → 59.7% → 56.9% → 59.5% → 60.5% → 62.9% → 63.4% | No supported explanation | improving; no threshold configured; confidence high | Primary source (2026-07-30) |
| Gross profit | $830M (Q2 FY2026) | $750.3M (Q1 FY2026) | $688.8M (Q2 FY2025) | +10.6% | +20.5% | $561.9M → $626.7M → $593.8M → $589M → $688.8M → $731.4M → $750.3M → $830M | The accepted Q2 filing reports the GAAP measures but does not provide a quantified driver bridge for every line; the related move is retained as an explicit unexplained reported change rather than attributed to a single cause. (unknown) | improving; no threshold configured; confidence high | Primary source (2026-07-30) |
| Net income attributable to common | $249.1M (Q2 FY2026) | $199.5M (Q1 FY2026) | $179.8M (Q2 FY2025) | +24.9% | +38.5% | $146.4M → $143.5M → $134.6M → $105.4M → $179.8M → $283.8M → $199.5M → $249.1M | The accepted Q2 filing reports the GAAP measures but does not provide a quantified driver bridge for every line; the related move is retained as an explicit unexplained reported change rather than attributed to a single cause. (unknown) | improving; no threshold configured; confidence high | Primary source (2026-07-30) |
| Operating cash flow | $269.2M (Q2 FY2026) | $525.6M (Q1 FY2026) | $303M (Q2 FY2025) | -48.8% | -11.2% | $209.2M → $279.4M → $199.5M → $183.8M → $303M → $659.9M → $525.6M → $269.2M | The accepted Q2 filing reports the GAAP measures but does not provide a quantified driver bridge for every line; the related move is retained as an explicit unexplained reported change rather than attributed to a single cause. (unknown) | deteriorating; no threshold configured; confidence high | Primary source (2026-07-30) |
| Operating income / EBIT | $318.3M (Q2 FY2026) | $255.3M (Q1 FY2026) | $212.6M (Q2 FY2025) | +24.7% | +49.7% | $101.1M → $158M → $152M → $133.7M → $212.6M → $242.5M → $255.3M → $318.3M | The accepted Q2 filing reports the GAAP measures but does not provide a quantified driver bridge for every line; the related move is retained as an explicit unexplained reported change rather than attributed to a single cause. (unknown) | improving; no threshold configured; confidence high | Primary source (2026-07-30) |
| Operating margin | 24.3% (Q2 FY2026) | 21.4% (Q1 FY2026) | 18.4% (Q2 FY2025) | +291 bps | +595 bps | 11% → 15.7% → 15.3% → 12.9% → 18.4% → 20.1% → 21.4% → 24.3% | No supported explanation | improving; no threshold configured; confidence high | Primary source (2026-07-30) |
| Revenue | $1.3B (Q2 FY2026) | $1.2B (Q1 FY2026) | $1.2B (Q2 FY2025) | +9.8% | +13.1% | $921M → $1B → $994.2M → $1B → $1.2B → $1.2B → $1.2B → $1.3B | No supported explanation | improving; no threshold configured; confidence high | Primary source (2026-07-30) |
Complete 12-quarter reported history
| KPI | Period | Value | QoQ | YoY | Source |
|---|---|---|---|---|---|
| Capital expenditures | Q2 FY2026 | $84.7M | +10.6% | -10.0% | Primary source (2026-07-30) |
| Capital expenditures | Q1 FY2026 | $76.6M | — | -12.0% | Primary source (2026-04-30) |
| Capital expenditures | Q3 FY2025 | $80.5M | -14.5% | -27.6% | Primary source (2025-10-30) |
| Capital expenditures | Q2 FY2025 | $94.1M | +8.2% | +42.4% | Primary source (2025-07-30) |
| Capital expenditures | Q1 FY2025 | $87M | — | +52.9% | Primary source (2025-05-01) |
| Capital expenditures | Q3 FY2024 | $111.2M | +68.2% | -39.6% | Primary source (2024-10-24) |
| Capital expenditures | Q2 FY2024 | $66.1M | +16.2% | — | Primary source (2024-07-25) |
| Capital expenditures | Q1 FY2024 | $56.9M | — | — | Primary source (2024-04-25) |
| Capital expenditures | Q3 FY2023 | $184.1M | — | — | Primary source (2023-10-26) |
| Cash and equivalents | Q2 FY2026 | $1.1B | — | — | Primary source (2026-07-30) |
| Diluted EPS | Q2 FY2026 | 0.64 | +25.5% | +42.2% | Primary source (2026-07-30) |
| Diluted EPS | Q1 FY2026 | 0.51 | — | +88.9% | Primary source (2026-04-30) |
| Diluted EPS | Q3 FY2025 | 0.7 | +55.6% | +105.9% | Primary source (2025-10-30) |
| Diluted EPS | Q2 FY2025 | 0.45 | +66.7% | +28.6% | Primary source (2026-07-30) |
| Diluted EPS | Q1 FY2025 | 0.27 | — | -25.0% | Primary source (2026-04-30) |
| Diluted EPS | Q3 FY2024 | 0.34 | -2.9% | +17.2% | Primary source (2025-10-30) |
| Diluted EPS | Q2 FY2024 | 0.35 | -2.8% | — | Primary source (2025-07-30) |
| Diluted EPS | Q1 FY2024 | 0.36 | — | — | Primary source (2025-05-01) |
| Diluted EPS | Q3 FY2023 | 0.29 | — | — | Primary source (2024-10-24) |
| Diluted weighted-average shares | Q2 FY2026 | 390.1M | -0.9% | -4.4% | Primary source (2026-07-30) |
| Diluted weighted-average shares | Q1 FY2026 | 393.6M | — | -3.4% | Primary source (2026-04-30) |
| Diluted weighted-average shares | Q3 FY2025 | 407.4M | -0.2% | -0.7% | Primary source (2025-10-30) |
| Diluted weighted-average shares | Q2 FY2025 | 408.2M | +0.2% | -2.1% | Primary source (2026-07-30) |
| Diluted weighted-average shares | Q1 FY2025 | 407.5M | — | -2.2% | Primary source (2026-04-30) |
| Diluted weighted-average shares | Q3 FY2024 | 410.2M | -1.6% | -3.9% | Primary source (2025-10-30) |
| Diluted weighted-average shares | Q2 FY2024 | 416.8M | +0.0% | — | Primary source (2025-07-30) |
| Diluted weighted-average shares | Q1 FY2024 | 416.7M | — | — | Primary source (2025-05-01) |
| Diluted weighted-average shares | Q3 FY2023 | 426.8M | — | — | Primary source (2024-10-24) |
| Free cash flow | Q2 FY2026 | $184.5M | -58.9% | -11.7% | Primary source (2026-07-30) |
| Free cash flow | Q1 FY2026 | $449M | — | +363.8% | Primary source (2026-07-30) |
| Free cash flow | Q3 FY2025 | $579.4M | +177.4% | +556.2% | Primary source (2026-07-30) |
| Free cash flow | Q2 FY2025 | $208.9M | +115.8% | -2.1% | Primary source (2026-07-30) |
| Free cash flow | Q1 FY2025 | $96.8M | — | -36.4% | Primary source (2026-07-30) |
| Free cash flow | Q3 FY2024 | $88.3M | -58.6% | -79.5% | Primary source (2026-07-30) |
| Free cash flow | Q2 FY2024 | $213.3M | +40.1% | — | Primary source (2026-07-30) |
| Free cash flow | Q1 FY2024 | $152.3M | — | — | Primary source (2026-07-30) |
| Free cash flow | Q3 FY2023 | $430.8M | — | — | Primary source (2026-07-30) |
| Gross margin | Q2 FY2026 | 63.4% | +49 bps | +391 bps | Primary source (2026-07-30) |
| Gross margin | Q1 FY2026 | 62.9% | — | +610 bps | Primary source (2026-04-30) |
| Gross margin | Q3 FY2025 | 60.5% | +95 bps | +75 bps | Primary source (2025-10-30) |
| Gross margin | Q2 FY2025 | 59.5% | +267 bps | -287 bps | Primary source (2026-07-30) |
| Gross margin | Q1 FY2025 | 56.9% | — | -416 bps | Primary source (2026-04-30) |
| Gross margin | Q3 FY2024 | 59.7% | -268 bps | -420 bps | Primary source (2025-10-30) |
| Gross margin | Q2 FY2024 | 62.4% | +139 bps | — | Primary source (2025-07-30) |
| Gross margin | Q1 FY2024 | 61% | — | — | Primary source (2025-05-01) |
| Gross margin | Q3 FY2023 | 63.9% | — | — | Primary source (2024-10-24) |
| Gross profit | Q2 FY2026 | $830M | +10.6% | +20.5% | Primary source (2026-07-30) |
| Gross profit | Q1 FY2026 | $750.3M | — | +27.4% | Primary source (2026-04-30) |
| Gross profit | Q3 FY2025 | $731.4M | +6.2% | +23.2% | Primary source (2025-10-30) |
| Gross profit | Q2 FY2025 | $688.8M | +16.9% | +9.9% | Primary source (2026-07-30) |
| Gross profit | Q1 FY2025 | $589M | — | +4.8% | Primary source (2026-04-30) |
| Gross profit | Q3 FY2024 | $593.8M | -5.2% | -4.7% | Primary source (2025-10-30) |
| Gross profit | Q2 FY2024 | $626.7M | +11.5% | — | Primary source (2025-07-30) |
| Gross profit | Q1 FY2024 | $561.9M | — | — | Primary source (2025-05-01) |
| Gross profit | Q3 FY2023 | $623.3M | — | — | Primary source (2024-10-24) |
| Interest Expense | Q2 FY2026 | $2.2M | +4.8% | -42.1% | Primary source (2026-07-30) |
| Interest Expense | Q1 FY2026 | $2.1M | — | -43.2% | Primary source (2026-04-30) |
| Interest Expense | Q3 FY2025 | $3.7M | -2.6% | +0.0% | Primary source (2025-10-30) |
| Interest Expense | Q2 FY2025 | $3.8M | +2.7% | +0.0% | Primary source (2026-07-30) |
| Interest Expense | Q1 FY2025 | $3.7M | — | +0.0% | Primary source (2026-04-30) |
| Interest Expense | Q3 FY2024 | $3.7M | -2.6% | — | Primary source (2025-10-30) |
| Interest Expense | Q2 FY2024 | $3.8M | +2.7% | — | Primary source (2025-07-30) |
| Interest Expense | Q1 FY2024 | $3.7M | — | — | Primary source (2025-05-01) |
| Net Income | Q2 FY2026 | $249.1M | +24.9% | +38.5% | Primary source (2026-07-30) |
| Net Income | Q1 FY2026 | $199.5M | — | +89.3% | Primary source (2026-04-30) |
| Net Income | Q3 FY2025 | $283.8M | +57.8% | +110.8% | Primary source (2025-10-30) |
| Net Income | Q2 FY2025 | $179.8M | +70.6% | +25.3% | Primary source (2026-07-30) |
| Net Income | Q1 FY2025 | $105.4M | — | -28.0% | Primary source (2026-04-30) |
| Net Income | Q3 FY2024 | $134.6M | -6.2% | +11.5% | Primary source (2025-10-30) |
| Net Income | Q2 FY2024 | $143.5M | -2.0% | — | Primary source (2025-07-30) |
| Net Income | Q1 FY2024 | $146.4M | — | — | Primary source (2025-05-01) |
| Net Income | Q3 FY2023 | $120.7M | — | — | Primary source (2024-10-24) |
| Net income attributable to common | Q2 FY2026 | $249.1M | +24.9% | +38.5% | Primary source (2026-07-30) |
| Net income attributable to common | Q1 FY2026 | $199.5M | — | +89.3% | Primary source (2026-04-30) |
| Net income attributable to common | Q3 FY2025 | $283.8M | +57.8% | +110.8% | Primary source (2025-10-30) |
| Net income attributable to common | Q2 FY2025 | $179.8M | +70.6% | +25.3% | Primary source (2026-07-30) |
| Net income attributable to common | Q1 FY2025 | $105.4M | — | -28.0% | Primary source (2026-04-30) |
| Net income attributable to common | Q3 FY2024 | $134.6M | -6.2% | +11.5% | Primary source (2025-10-30) |
| Net income attributable to common | Q2 FY2024 | $143.5M | -2.0% | — | Primary source (2025-07-30) |
| Net income attributable to common | Q1 FY2024 | $146.4M | — | — | Primary source (2025-05-01) |
| Net income attributable to common | Q3 FY2023 | $120.7M | — | — | Primary source (2024-10-24) |
| Operating cash flow | Q2 FY2026 | $269.2M | -48.8% | -11.2% | Primary source (2026-07-30) |
| Operating cash flow | Q1 FY2026 | $525.6M | — | +186.0% | Primary source (2026-04-30) |
| Operating cash flow | Q3 FY2025 | $659.9M | +117.8% | +230.8% | Primary source (2025-10-30) |
| Operating cash flow | Q2 FY2025 | $303M | +64.9% | +8.4% | Primary source (2025-07-30) |
| Operating cash flow | Q1 FY2025 | $183.8M | — | -12.1% | Primary source (2025-05-01) |
| Operating cash flow | Q3 FY2024 | $199.5M | -28.6% | -67.6% | Primary source (2024-10-24) |
| Operating cash flow | Q2 FY2024 | $279.4M | +33.6% | — | Primary source (2024-07-25) |
| Operating cash flow | Q1 FY2024 | $209.2M | — | — | Primary source (2024-04-25) |
| Operating cash flow | Q3 FY2023 | $614.9M | — | — | Primary source (2023-10-26) |
| Operating income / EBIT | Q2 FY2026 | $318.3M | +24.7% | +49.7% | Primary source (2026-07-30) |
| Operating income / EBIT | Q1 FY2026 | $255.3M | — | +90.9% | Primary source (2026-04-30) |
| Operating income / EBIT | Q3 FY2025 | $242.5M | +14.1% | +59.5% | Primary source (2025-10-30) |
| Operating income / EBIT | Q2 FY2025 | $212.6M | +59.0% | +34.6% | Primary source (2026-07-30) |
| Operating income / EBIT | Q1 FY2025 | $133.7M | — | +32.2% | Primary source (2026-04-30) |
| Operating income / EBIT | Q3 FY2024 | $152M | -3.8% | -26.0% | Primary source (2025-10-30) |
| Operating income / EBIT | Q2 FY2024 | $158M | +56.3% | — | Primary source (2025-07-30) |
| Operating income / EBIT | Q1 FY2024 | $101.1M | — | — | Primary source (2025-05-01) |
| Operating income / EBIT | Q3 FY2023 | $205.5M | — | — | Primary source (2024-10-24) |
| Operating margin | Q2 FY2026 | 24.3% | +291 bps | +595 bps | Primary source (2026-07-30) |
| Operating margin | Q1 FY2026 | 21.4% | — | +851 bps | Primary source (2026-04-30) |
| Operating margin | Q3 FY2025 | 20.1% | +168 bps | +476 bps | Primary source (2025-10-30) |
| Operating margin | Q2 FY2025 | 18.4% | +547 bps | +264 bps | Primary source (2026-07-30) |
| Operating margin | Q1 FY2025 | 12.9% | — | +193 bps | Primary source (2026-04-30) |
| Operating margin | Q3 FY2024 | 15.3% | -44 bps | -579 bps | Primary source (2025-10-30) |
| Operating margin | Q2 FY2024 | 15.7% | +476 bps | — | Primary source (2025-07-30) |
| Operating margin | Q1 FY2024 | 11% | — | — | Primary source (2025-05-01) |
| Operating margin | Q3 FY2023 | 21.1% | — | — | Primary source (2024-10-24) |
| Revenue | Q2 FY2026 | $1.3B | +9.8% | +13.1% | Primary source (2026-07-30) |
| Revenue | Q1 FY2026 | $1.2B | — | +15.0% | Primary source (2026-04-30) |
| Revenue | Q3 FY2025 | $1.2B | +4.5% | +21.6% | Primary source (2025-10-30) |
| Revenue | Q2 FY2025 | $1.2B | +11.7% | +15.2% | Primary source (2026-07-30) |
| Revenue | Q1 FY2025 | $1B | — | +12.5% | Primary source (2026-04-30) |
| Revenue | Q3 FY2024 | $994.2M | -1.0% | +2.0% | Primary source (2025-10-30) |
| Revenue | Q2 FY2024 | $1B | +9.0% | — | Primary source (2025-07-30) |
| Revenue | Q1 FY2024 | $921M | — | — | Primary source (2025-05-01) |
| Revenue | Q3 FY2023 | $975M | — | — | Primary source (2024-10-24) |
Thesis signals
Thesis pillars
- Adoption sustains double-digit growthBroader access, patient starts, and recurring sensor use keep quarterly revenue above the operating baseline.
- Manufacturing and mix produce operating leverageGross-margin recovery converts revenue growth into faster operating-income growth.
- Cash generation funds innovationPositive free cash flow and modest net debt support product cadence without external financing.
- Per-share economics remain intactDiluted shares remain controlled while earnings and intrinsic cash flow grow.
Catalysts
- Access expansionCoverage expansion and penetration beyond intensive insulin users can enlarge the addressable base.
- Product cadenceG7 15-Day, Stelo and G8 milestones can improve reach, experience and retention.
Risks
- Quality and reliabilityA material product-quality event could damage trust, adoption and remediation costs.
- Competition, reimbursement and regulationPricing, access, approval or product pressure could slow starts and compress margins.
Monitoring triggers
- Growth gateactive
- Margin gateactive
- Cash and dilution gateactive
Evidence limits
Conflicts
- None reported.
Gaps
- Itemgap
Public sources
- Primary source (2026-07-30)
- Primary source (2026-04-30)